Publications by authors named "Juha Hartikainen"

Claim this Profile
T
The use of antiarrhythmic drugs for atrial fibrillation in Finland 2007-2018.
Rasmus Siponen, Juha Hartikainen, Janne Virrankorpi, Antti Lappalainen, Konsta Teppo

Scand Cardiovasc J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Differences Between Oral Anticoagulation Therapies in Patients with Atrial Fibrillation in Finland.
Ossi Lehtonen, Olli Halminen, K E Juhani Airaksinen, Jari Haukka, Jukka Putaala, Juha Hartikainen

Drugs Real World Outcomes· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomics of aortic valve stenosis: Are aortic valve stenosis and sclerosis different diseases?
Elisa Koljonen, Olli Kärkkäinen, Retu Haikonen, Anu Turpeinen, Juha Hartikainen

Atherosclerosis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How much does elective cardioversion increase the risk of ischaemic stroke compared to the baseline risk in atrial fibrillation? A nationwide study.
Saga Itäinen-Strömberg, Mika Lehto, Olli Halminen, Jari Haukka, Jukka Putaala, Juha Hartikainen

Europace· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral anticoagulation in patients with gastrointestinal bleeding and new-onset atrial fibrillation: A population-based registry-linkage study.
Santeri Jolkkonen, Jukka Putaala, Konsta Teppo, Pirjo Mustonen, Jussi Jaakkola, Juha Hartikainen

J Intern Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prehospital Fibrinolysis in High-Risk Pulmonary Embolism - Observational Data on Clinical Picture and Outcome.
Johanna Harjola, Peter Holmström, Markus Sane, Juha Hartikainen, Veli-Pekka Harjola

Prehosp Emerg Care· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) Trial-IMAGE HF Project 1A.
Lisa M Mielniczuk, Eileen O'Meara, Christiane Wiefels, Li Chen, Linda Garrard, Juha Hartikainen

CJC Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early substrate-based catheter ablation vs. antiarrhythmic drug therapy for ventricular tachyarrhythmias among patients with prior myocardial infarction: the MANTRA-VT randomized trial.
Pekka Raatikainen, Heikki Mäkynen, Juha Hartikainen, Mats Jensen Urstad, Leena Konkola

Europace· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of anticoagulation and outcomes after mechanical aortic valve replacement in patients with atrial fibrillation: a nationwide cohort study.
Joonas Lehto, Rikhard Björn, Olli Halminen, Miika Linna, Jari Haukka, Juha Hartikainen

Eur Heart J Qual Care Clin Outcomes· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous thromboembolisms and stroke risk in patients with atrial fibrillation: a nationwide cohort study.
Eero Jalli, Jussi Jaakkola, Ville Langén, K E Juhani Airaksinen, Olli Halminen, Juha Hartikainen

Europace· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart Failure and Stroke Risk in Atrial Fibrillation: Temporal Trends From a Nationwide Cohort Study.
Eero Jalli, Ville Langén, Jussi Jaakkola, K E J Airaksinen, Olli Halminen, Juha Hartikainen

J Am Heart Assoc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photoplethysmography in recent-onset atrial fibrillation: automatic detection of rhythm change and burden.
Olli A Rantula, Jukka A Lipponen, Jari Halonen, Helena Jäntti, Tuomas T Rissanen, Juha E K Hartikainen

Eur Heart J Digit Health· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemorrhagic Stroke in Atrial Fibrillation: Trends in Incidence, Case Fatality, and Prior Oral Anticoagulation.
Paula Tiili, Mika Lehto, Olli Halminen, Jari Haukka, Ossi Lehtonen, Juha Hartikainen

J Am Heart Assoc· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with oral anticoagulant non-use at first ischemic stroke in atrial fibrillation: A nationwide study.
Marko Vilpponen, Aapo L Aro, Olli Halminen, Paula Tiili, Miika Linna, Juha Hartikainen

Eur Stroke J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alcohol use disorder and initiation of oral anticoagulant therapy in patients with atrial fibrillation: A nationwide cohort study.
Miika Vanhanen, Jussi Jaakkola, Juhani K E Airaksinen, Olli Halminen, Jukka Putaala, Juha Hartikainen

Gen Hosp Psychiatry· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced dose direct oral anticoagulants and time-in-therapeutic-range defined warfarin in new-onset atrial fibrillation: a report from the nationwide FinACAF study.
Alex Luojus, Mika Lehto, Olli Halminen, Ossi Lehtonen, Mikko Niemi, Juha Hartikainen

Eur Heart J Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing feasibility and reproducibility of pacing-induced heart failure model in pigs.
Jaakko Lampela, Niko Järveläinen, Anni Määttä, Satu Siimes, Minja Heikkilä, Juha Hartikainen

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Trends of Ischemic Stroke Risk in Patients With Incident Atrial Fibrillation Before Anticoagulation.
Konsta Teppo, K E Juhani Airaksinen, Olli Halminen, Jussi Jaakkola, Jari Haukka, Juha Hartikainen

JACC Clin Electrophysiol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelialization of coronary stents after intra-luminal adenoviral VEGF-A gene transfer in a preclinical porcine restenosis model - Studies with optical coherence tomography, angioscopy, multiphoton and scanning electron microscopy.
Jarkko P Hytönen, Juho Pajula, Paavo Halonen, Jouni Taavitsainen, Antti Kuivanen, Juha Hartikainen

J Mol Cell Cardiol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QClus: a droplet filtering algorithm for enhanced snRNA-seq data quality in challenging samples.
Eloi Schmauch, Johannes Ojanen, Kyriakitsa Galani, Juho Jalkanen, Kristiina Harju, Juha Hartikainen

Nucleic Acids Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular disease and ischemic stroke in patients with atrial fibrillation: Temporal trends and age-related differences.
Konsta Teppo, Elin Karlsson, Tuomas Kiviniemi, Olli Halminen, Ossi Lehtonen, Juha Hartikainen

Atherosclerosis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal trends of catheter ablation procedures in patients with atrial fibrillation and atrial flutter: A nationwide cohort study.
Antti Lappalainen, Juha E K Hartikainen, Konsta Teppo, Olli Halminen, Aapo L Aro

Int J Cardiol Heart Vasc· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex- and age-specific differences in the use of antiarrhythmic therapies among atrial fibrillation patients: a nationwide cohort study.
Birgitta Salmela, Jussi Jaakkola, Ksenia Kalatsova, Jaakko Inkovaara, Aapo L Aro, Juha Hartikainen

Europace· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical development and proof of principle testing of new regenerative vascular endothelial growth factor-D therapy for refractory angina: rationale and design of the phase 2 ReGenHeart trial.
Aleksi J Leikas, Juha E K Hartikainen, Jens Kastrup, Anthony Mathur, Mariann Gyöngyösi

Open Heart· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal trends in mortality and causes of death in patients with incident atrial fibrillation: a nationwide register study from 2010 to 2018.
Elis Kouki, Birgitta Salmela, Aapo Aro, Olli Halminen, Konsta Teppo, Juha Hartikainen

BMJ Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis